Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.

Overview of attention for article published in Journal of Clinical Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 2 news outlets
twitter: 71 X users
facebook: 1 Facebook page

f1000: 1 research highlight platform
guideline: 3 clinical guideline sources

Readers on

mendeley: 133 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study

UBM Medica, 26 Mar 2026

Introduction Soft tissue sarcoma (STS) is an aggressive malignant tumor that accounts for 1% and 25% of all cancers in adults…

Neoadjuvant Trabectedin Noninferior to Standard Care for High-Grade Myxoid Liposarcoma

Cancer Therapy Advisor, 31 Jan 2024

Neoadjuvant trabectedin may be an alternative to standard chemotherapy for patients with high-grade myxoid liposarcoma of the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.